A survey of hallucinogenic mushroom use, factors related to usage, and perceptions of use among college students

Drug and Alcohol Dependence

Volumn 130, Issue 1-3, 2013, Pages 245-248

  Hallock, Robert M ^a   Dean, Andrew ^b   Knecht, Zachary A ^b   Spencer, Jared ^b   Taverna, Elise C ^a  

^a Surgical Metabolism and Nutrition Laboratory   (United States)

^b Dept of Biology ^*  (United States)

Author keywords

College drug use; Drug trends; Mushrooms; Psilocybe; Psilocybin

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; CANNABIS; COCAINE; LYSERGIDE; OPIATE; PRESCRIPTION DRUG; PSILOCYBINE;

ACADEMIC ACHIEVEMENT; ADULT; ALCOHOL CONSUMPTION; ARTICLE; ATTITUDE; COLLEGE STUDENT; CONTROLLED STUDY; DECISION MAKING; DRUG ABUSE; DRUG DEPENDENCE; DRUG USE; EXPERIENCE; FEMALE; HEALTH; HUMAN; MALE; MENTAL HEALTH; MULTIPLE DRUG ABUSE; MUSHROOM; PERCEPTION; PRIORITY JOURNAL; RANDOMIZATION; TOBACCO; UNITED STATES;

ADOLESCENT; ADULT; AGARICALES; FEMALE; HALLUCINOGENS; HUMANS; MALE; PERCEPTION; PSILOCYBINE; STREET DRUGS; STUDENTS; SUBSTANCE-RELATED DISORDERS; UNIVERSITIES; YOUNG ADULT;

BASIDIOMYCOTA; CANNABIS SATIVA; NICOTIANA TABACUM; PSILOCYBE;

EID: 84877052958     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2012.11.010     Document Type: Article

References (18)

1. Anglin M.D., Thompson J.P., Fisher D.G. Parental, personality, and peer correlates of psychoactive mushroom use. J. Drug Educ. 1986, 16:2265-2285.
2. Barrett S.P., Darredeau C., Pihl R.O. Patterns of simultaneous polysubstance use in drug using university students. Hum. Psychopharmacol. 2006, 21:255-263.
3. Griffiths R.R., Richards W.A., McCann U., Jesse R. Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology (Berl) 2006, 187:268-283.
4. Grob C.S., Danforth A.L., Chopra G.S., Hagerty M., McKay C.R., Halberstadt A.L., Greer G.R. Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. Arch. Gen. Psychiatry 2011, 68:71-78.
5. Guzmán G. Species diversity of the genus Psilocybe (Basidiomycotina, Agaricales, Strophariaceae) in the world mycobiota, with special attention to hallucinogenic properties. Int. J. Med. Mushrooms 2005, 7:305-322.
6. Hollister L.E. Clinical, biochemical, and psychologic effects of psilocybin. Arch. Int. Pharmacodyn. Ther. 1961, 130:42-52.
7. Isbell H. Comparison of the reactions induced by psilocybin and LSD-25 in man. Psychopharacologia 1959, 1:29-38.
8. Johnson M.W., Sewell R.A., Griffiths R.R. Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers. Drug Alcohol Depend. 2011, 123:132-140.
9. Malitz S., Esecover H., Wilkens B., Hoch P.H. Some observations on psilocybin, a new hallucinogen, in volunteer subjects. Compr. Psychiatry 1960, 1:8-17.
10. Passie T., Seifert J., Schneider U., Emrich H.M. The pharmacology of psilocybin. Addict. Biol. 2002, 7:357-364.
11. Pierce J.P., Disefan J.M., Kaplan R.M., Gilpin E.A. The role of curiosity in smoking initiation. Addict. Behav. 2005, 30:685-696.
12. Schultes R.E., Hofmann A. Plants of the Gods: Origins of Hallucinogenic Use 1979, McGraw-Hill, New York.
13. Stamets P. Psilocybin Mushrooms of the World 1996, Ten Speed Press, Berkeley, CA.
14. Substance Abuse and Mental Health Services Administration, 2011. Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings. NSDUH Series H-41, HHS Publication No. (SMA) 11-4658, Rockville, MD.
15. Vollenweider F.X., Vollenweider-Scherpenhuyzen M.F., Bäbler A., Vogel H., Hell D. Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action. Neuroreport 1998, 9:3897-3902.
16. Wasson R.G. The Wondrous Mushroom: Mycolatry in Mesoamerica 1980, McGraw-Hill, New York.
17. Wittmann M., Carter O., Cahn B.R., Grimberg U., Spring P., Hell D., Flohr H., Vollenweider F.X. Effects of psilocybin on time perception and temporal control of behaviour in humans. J. Psychpharmacol. 2007, 21:50-64.
18. Wolbach A.B., Miner E.J., Isbell H. Comparison of psilocin with psilocybin, mescaline and LSD-25. Psychopharmacologia 1962, 3:219-223.